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ABSTRACT 22 
Background: Psychological morbidity in inflammatory bowel disease is common 23 
with significant impact on quality of life and health outcomes, but factors which 24 
predict the development of psychological morbidity are unclear.  25 
 26 
Aim: To undertake a systematic literature review of the predictors of psychological 27 
morbidity in patients with inflammatory bowel disease.  28 
 29 
Methods: Electronic searches for English-language articles were performed with 30 
keywords relating to psychological morbidity according to the Diagnostic and 31 
Statistical Manual of Mental Disorders IV and subsequent criteria, and inflammatory 32 
bowel disease; in MEDLINE, PsychInfo, Web of Science and EMBASE for studies 33 
published from January 1997 to the 25th January 2019.  34 
 35 
Results: Of 660 studies identified, seven met the inclusion criteria.  All measured 36 
depression, with three also measuring anxiety. Follow-up duration was variable  37 
(median of 18 months range 6  96 months). Risk factors identified for development 38 
of psychological morbidity included physical factors: aggressive disease [HR 5.77, 39 
95% CI = 1.89  17.7] and greater comorbidity burden [OR 4.31, 95% CI = 2.83  40 
6.57] and psychological risk factors: degree of gratitude [r = -0.43, p < 0.01] and 41 
parenting stress [R-change = 0.03, F(1,58) = 35.6, p < 0.05]. Age-specific risk were 42 
identified with young people (13  17 years) at increased risk.  43 
 
Conclusions: Identifiable risks for the development of psychological morbidity in 44 
inflammatory bowel disease include physical and psychological factors. Further 45 
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research is required from large prospective studies to enable early interventions in 46 
those at risk and reduce the impact of psychological morbidity.  47 
 48 
Keywords: inflammatory bowel disease, psychological morbidity, prediction 49 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION  50 
Inflammatory bowel disease (IBD), encompassing both Crohns disease (CD) and 51 
ulcerative colitis (UC) can present at any age but is most frequently diagnosed 52 
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during the second and third decades of life (1). Psychological morbidity is widely 53 
reported in patients with IBD (24) with prevalence rates as high as 50% (2), and is 54 
associated with failure to gain work and loss of employment (5,6), increased rates of 55 
sick leave (7), reduced work productivity (8) and increased utilisation of health 56 
services (9) including early rehospitalisation (10) thereby increasing the economic 57 
burden of IBD (11). Further data shows that patients with IBD and psychological 58 
morbidity such as depression, are at an increased risk for reduced treatment 59 
adherence (12) and poorer self-management behaviours including diet, exercise and 60 
smoking (13).  61 
 62 
Systematic reviews (1418) have highlighted the increased levels of psychological 63 
morbidity in IBD, but limited research exists to identify risk factors for future 64 
development of psychological morbidity in IBD.  Those risk factors identified, such as 65 
increased disease severity (17,18), younger age at diagnosis and lower 66 
socioeconomic status (16) are derived predominantly from cross-sectional studies 67 
within the systematic reviews (range 89-93%) (1416). Longitudinal studies are 68 
necessary to identify factors that are able to predict the development of 69 
psychological morbidity.  70 
 71 
Prediction of future psychological morbidity in IBD patients is of importance to enable 72 
early intervention and improve patient outcomes. The aim of this systematic review is 73 
to examine the available evidence regarding factors which predict the development 74 
of psychological morbidity in people with IBD.  75 
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REVIEW CRITERIA AND METHODOLOGY  76 
This systematic review was conducted according to the Preferred Reporting Items 77 
for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (19). 78 
 79 
Data Sources and Search Strategy  80 
A systematic literature search was undertaken using four relevant databases: 81 
Medline (via Ovid), EMBASE, Web of Science and PsychInfo (Scopus) aiming to 82 
capture all relevant studies across disciplines including psychology, psychiatry, 83 
paediatric and adult gastroenterology over a 20 year period. The date of the 84 
literature search was 25th of January 2019, with the search conducted from the 1st 85 
January 1997.  Table 1 shows title, abstract and keyword search terms relating to 86 
prediction, inflammatory bowel disease and psychological morbidity as defined 87 
by the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (20). 88 
Duplicate abstracts were eliminated.  89 
 90 
Study Eligibility and Selection Criteria 91 
Three authors (A.B.H, A.J.B, A.J.L) determined study eligibility to ensure reliability of 92 
the selection process. Studies were initially screened by the first author and 93 
decisions about study inclusion were made independently by all three authors. 94 
Concerns and disagreements were discussed and a final agreement was reached.  95 
 96 
Abstracts were screened to assess whether they met the following inclusion criteria: 97 
(i) published in full, in a peer-reviewed journal and written in English (ii) included 98 
outcome measures pertaining to psychological distress at baseline and follow-up and 99 
(iii) included extractable data on participants/patients with IBD diagnoses. Exclusion 100 
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criteria were (i) case studies or non-empirical studies (e.g. narrative reports, reviews) 101 
(ii) studies showing associations at one time point rather than predicting the 102 
development of psychological morbidity using follow-up data (iii) reviews, editorials 103 
and conference abstracts (iv) intervention studies. Additional studies of interest were 104 
searched for by hand in bibliographies and cited references of identified papers and 105 
by consultation with clinical experts in the field. The flow chart of study selection can 106 
be seen in Figure 1.   107 
 108 
 109 
Data Extraction   110 
Data extracted from the studies is outlined in the supplementary data and in Tables 111 
2, 3a and 3b. Data included country of study, participant gender, age and diagnosis, 112 
length of study follow up and study design, type of assessment for psychological 113 
morbidity and type of analysis conducted. Retention rate was included where 114 
relevant, and significant outcomes were recorded.  115 
 116 
Table 1. Search Terms for Systematic Review 
Psychological morbidity 
terms 
AND Prediction terms AND IBD terms 
Affective disorder OR 
Anxiety OR Depression 
OR Depressive OR 
Eating Disorder OR 
Mental disorder OR 
Mental health OR Mood 
disorder OR Personality 
disorder OR 
Psychological distress 
OR Psychotic OR 
Schizophren* Or 
Somatoform disorder 
Forecast OR 
Forecasting OR Predict* 
OR Predictive method OR 
Projection OR Risk 
 Colitis OR Crohns 
disease OR IBD OR 
Inflammatory bowel 
disease OR 
Ulcerative Colitis 
Search limited to English-language articles 
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Quality Assessment 117 
Both ABH and AJB conducted a formal assessment of study quality using the 118 
GRADE system (21). Assessments were conducted individually and discrepancies 119 
between coders were resolved through discussion.   120 
 121 
RESULTS 122 
Factors which predicted the development of psychological morbidity in patients with 123 
IBD were categorised as: physical and psychological factors.  Factors included in the 124 
studies examined are summarised in Table 2, and the outcomes in Table 3a and 3b. 125 
 126 
Table 2. Factors examined for their value in predicting the development of psychological morbidity 
in people with IBD. 
Study 
(reference) 
Ananthakrishnan et 
al (22) 
Gracie 
et al (23) 
Guilfoyle 
et al (24) 
Loftus 
et al 
(25) 
Panara 
et al (26) 
Sirois and 
Wood (27) 
Trindade et 
al (28) 
Active Disease  9   9   
Severe 
Disease 
9 for depression in CD 
(surgery within 3 
years, 
immunomodulator use, 
stoma surgery, 
perianal disease) 
 
9 for anxiety in UC 
(surgery within 3 
years, stoma surgery, 
VXUJHULHV 
 
X for UC 
   9   
Gender 9 female   9 male 9 female   
Age 9 for anxiety in UC 
X for depression in UC 
and 
anxiety/depression in 
CD 
  9 X   
Comorbidity 9        
Gratitude      9  
Parenting 
Stress 
  9     
Symptom 
Burden 
      9 
9  = Examined and found to be a significant predictor 
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X = Examined but found not to be a significant predictor 
 127 
Table 3a. Physical Factors predictive of the development of psychological morbidity in people with 
inflammatory bowel disease 
Identified 
predictive 
factor 
Study 
(reference),  
Country 
Follow up 
duration 
Significant outcomes Non-significant outcomes 
Active 
Disease 
Gracie et al (23), 
Germany 
2 year minimum Harvey Bradshaw Index or Simple 
Clinical Colitis Activity Index  t5: 
Anxiety [HR = 5.77, 95% CI = 
1.89  17.7, p = 0.03] 
Baseline disease activity and 
development of depression p = 
0.89 
 Panara et al 
(26), 
USA 
8 years (S.D 3.8) Endoscopic and radiological 
assessment: 
Depression [HR = 1.5, 95% CI = 
1.1  2.0, p = 0.04] 
N/A 
Severe 
Disease 
Ananthakrishnan 
et al (22),  
USA 
1, 2 and 5 years Immunomodulator use: 
Crohns disease depression [OR 
= 1.5, 95% CI = 1.03  2.38] 
 
Perianal Disease: 
Crohns disease depression [OR 
= 1.64, 95% CI = 1.01  2.69] 
 
Stoma surgery:  
Crohns disease anxiety [OR = 
1.73, 95% CI = 1.05  2.85] 
 
Crohns disease depression [OR 
= 1.90, 95% CI = 1.15  3.13] 
 
Surgery d3 years of diagnosis: 
Crohns disease anxiety [OR = 
2.19, 95% CI = 1.44  3.33] 
Crohns disease depression [OR 
= 1.54, 95% CI = 1.01  2.37] 
 
d2 Surgeries: 
Crohns disease anxiety [OR = 
1.79, 95% CI = 1.09  2.93] 
Immunmodulator use:  
Ulcerative colits depression 
Ulcerative colitis anxiety 
Crohns disease anxiety 
 
Perianal disease: 
Ulcerative colitis depression 
Ulcerative colitis anxiety 
Crohns disease anxiety 
 
Stoma surgery: 
Ulcerative colitis depression 
Ulcerative colitis anxiety 
 
Surgery d3 years diagnosis: 
Ulcerative colitis depression 
Ulcerative colitis anxiety 
 
d2 Surgeries: 
Ulcerative colitis depression 
Ulcerative colitis anxiety 
Crohns disease depression 
 Panara et al 
(26), 
USA 
8 years (S.D 3.8) Aggressive disease: 
Depression [HR = 1.4, 95% CI = 
1.02  1.9, p = 0.03] 
Use of mesalazine: 
Depression [HR 0.83, 95% CI 
= 0.64  1.07, p = 0.16] 
 
Perianal disease: 
Depression [HR 1.2, 95% CI 
0.89  1.62, p = 0.24] 
 
History of IBD surgery: 
Depression [HR 1.3, 95% CI = 
0.92  1.76, p =0.13] 
Age Ananthakrishnan 
et al (22), 
USA 
1, 2 and 5 years Age per 1 year: 
Ulcerative colitis anxiety [OR = 
0.98, 95% CI = 0.91  1.00] 
Age per 1 year: 
Ulcerative colitis depression  
Crohns disease anxiety  
Crohns disease depression 
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 Loftus et al (25),  
USA 
t6 months Girls 13  17: 
Anxiety [HR = 2.45, 95% CI = 
1.41  4.25, p = 0.0014] 
 
Boys 0  12: 
Depression [HR = 2.55, 95% CI = 
1.15  5.67, p = 0.0216] 
 
Boys 13  17: 
Depression [HR = 1.99, 95% CI = 
1.32  3.02, p = 0.0011] 
Anxiety [HR = 3.01, 95% CI = 
1.73  5.24, p < 0.0001] 
Girls 0  12: 
Depression [HR 2.24, 95% CI 
= 0.95  5.31, p = 0.0665] 
Anxiety [HR 1.48, 95% CI = 
0.56  3.88, p = 0.427] 
 
Girls 13  17: 
Depression [HR 1.30, 95% CI 
= 0.87  1.95, p = 0.2028] 
 
Boys 0 -12: 
Anxiety [HR 1.60, 95% CI = 
0.68  3.75, p = 0.2776] 
 Panara et al 
(26), 
USA 
8 years (S.D 3.8) N/A Age t40 years: 
Depression [HR = 1.3, 95% CI 
= 0.88  1.82, p = 0.18] 
Comorbidity Ananthakrishnan 
(22), 
USA 
1,2 and 5 years Charlson Score t3: 
Crohns disease anxiety [OR = 
1.84, 95% CI = 1.44  3.33] 
Ulcerative colitis anxiety [OR = 
3.26, 95% CI = 1.98  5.38] 
Crohns disease depression [OR 
= 4.31, 95% CI = 2.82  6.57] 
Ulcerative colitis depression [OR 
= 3.73, 95% CI = 2.33  5.97] 
N/A 
Gender Ananthakrishnan 
et al (22),  
USA 
1,2 and 5 years Female Gender: 
Crohns disease depression [OR 
= 1.77, 95% CI = 1.16  2.71]  
Ulcerative colitis depression [OR 
= 2.92, 95% CI = 1.80  4.76] 
Crohns disease anxiety [OR = 
2.07, 95% CI = 1.35  3.19] 
Ulcerative colitis anxiety [OR = 
1.84, 95% CI = 1.18  2.87] 
N/A 
 Loftus et al (25), 
USA 
t6 months Girls 13  17: 
Anxiety [HR = 2.45, 95% CI = 
1.41  4.25] 
 
Boys 0  12:  
Depression [HR = 2.55, 95% CI = 
1.15  5.67] 
 
Boys 13  17: 
Depression [HR = 1.99, 95% CI = 
1.32  3.02] 
Anxiety [HR = 3.01, 95% CI = 
1.73  5.24] 
Girls 0  12: 
Depression [HR 2.24, 95% CI 
= 0.95  5.31, p = 0.0665] 
Anxiety [HR 1.48, 95% CI = 
0.56  3.88, p = 0.427] 
 
Girls 13  17: 
Depression [HR 1.30, 95% CI 
= 0.87  1.95, p = 0.2028] 
 
Boys 0 -12: 
Anxiety [HR 1.60, 95% CI = 
0.68  3.75, p = 0.2776] 
 Panara et al 
(26), 
USA 
8 years (S.D 3.8) Female Gender:  
Depression [HR = 1.3, 95% CI = 
1.1  1.7, p = 0.01] 
N/A 
 128 
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Table 3b. Psychological factors predictive of the development of psychosocial 
morbidity in people with inflammatory bowel disease 
Identified 
predictive factor 
Study 
(reference), 
Country 
Follow up 
duration 
Significant 
outcomes 
Non-significant 
outcomes 
Gratitude Sirois and Wood 
(27), 
USA and Canada 
6 months Depression [r = -
0.43, p < 0.01] 
N/A 
Parenting Stress Guilfoyle et al 
(24), 
USA 
6 months Depression [R-
change = 0.03, 
F(1,58) = 35.6, p 
< 0.05] 
N/A 
Symptomatology Trindade et al 
(28), 
Portugal 
18 months Symptomatology:  
r = 0.25, p < 0.01 
N/A 
 129 
Study Characteristics 130 
Seven studies were identified (see Fig 1), five in adult cohorts and two in paediatric 131 
cohorts, specifically 13  17 years (24) and <18 years (25). Of these, five were 132 
undertaken in the United States (22,2427), of which one also recruited from 133 
Canada (27). Two studies were undertaken in Europe (23,28). The median number 134 
of participants was 427 (range 93  12864), female predominance (median 57.2%, 135 
range 43.0% - 88.1%), median age 43 years (range 15.5  48 years), with an IBD 136 
type of 30.2% UC and 68.8% CD was evident. The median longitudinal follow-up 137 
was 18 months (range 6  96 months), with a median reported retention rate at 138 
follow-up of 55.8% (range 33.7  69.8%).  139 
 140 
Assessment of Psychological Morbidity 141 
Three studies assessed the development of both anxiety and depression. Two of 142 
these used the International Classification of Diseases (ICD-9) (22,25) and one used 143 
the Hospital Anxiety and Depression Scale (HADS) (23). The remaining studies 144 
assessed the development of depression only, with all applying different measures 145 
(24,2628).  146 
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 147 
Statistical Analysis 148 
Regression models were the most commonly utilised statistical method (n = 6) (22149 
27), one study used a cross-lagged panel analysis (28).  150 
 151 
GRADE Assessment 152 
Of the seven studies, three were graded as low, three moderate and one as high 153 
quality.   154 
 155 
Physical Factors Predicting Psychological Morbidity  156 
Active Disease  157 
Physical factors shown to be predictive of psychological morbidity include disease 158 
activity (23,26). Gracie et al found that higher disease activity at baseline was 159 
predictive of the development of anxiety after a two-year follow-up period [HR 5.77, 160 
95% CI = 1.89  17.7, p = 0.03] (23). This study defined active disease using a 161 
Harvey-Bradshaw Index or Simple Clinical Colitis Activity Index of t5 for CD and UC 162 
respectively (23). The prevalence of depression in this study was too low to allow 163 
conclusions to be drawn regarding the factors predicting its development. Panara et 164 
al identified that depression was predicted by endoscopic and radiological disease 165 
activity [HR  1.5, 95% CI = 1.1 2.0, p = 0.04] (26) Endoscopic disease activity was 166 
defined as the presence of any inflammatory changes in the GI mucosa due to the 167 
patients IBD (26). Radiological disease activity was defined as the presence of any 168 
abnormal findings in cross-sectional imaging secondary to the patients IBD, 169 
including strictures, tract inflammation and pelvic collections (26).     170 
 171 
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Severe Disease 172 
Panara et al defined aggressive disease as prior or current surgery for IBD, the use 173 
of one or more biologic drugs at any time during the disease course or perianal 174 
involvement and/or fistulating disease (26). They identified patients with this 175 
composite endpoint as being at increased risk of developing depression [HR 1.4, 176 
95% CI = 1.02  1.9, p = 0.03] at a mean follow-up of 8 years. Importantly none of 177 
the individual factors were independently predictive of development of depression 178 
after multivariate analysis.  179 
 180 
Ananthakrishnan et al examined factors predicting psychological morbidity in 181 
patients who had undergone bowel resection or required hospitalisation, rather than 182 
in the general IBD population (22). CD patients who underwent stoma surgery were 183 
at approximately twofold increased risk of developing depression [adjusted OR 1.90, 184 
95% CI = 1.15  3.13]. In terms of potential markers of disease severity, 185 
immunomodulator use was associated with an increased risk of developing 186 
depression [adjusted OR 1.56, 95% CI 1.03  2.38] for CD. UC patients who 187 
underwent surgery within 3 years from initial diagnosis had more than a twofold 188 
increased risk of developing anxiety [adjusted OR 2.19, 95% CI = 1.44  3.33], with 189 
stoma surgery associated with an adjusted OR of 1.73, 95% CI = 1.05  2.85. 190 
However, these factors were not significantly predictive of the development of 191 
psychological morbidity in ulcerative colitis when multivariate analysis was performed 192 
(22).  193 
 194 
Age 195 
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The relationship between age and development of psychological morbidity is 196 
complex. Two studies identified age as a potential predictive factor for the 197 
development of psychological morbidity (22,25), whilst another did not find a 198 
significant relationship (26). Ananthakrishnan et al found that older age at time of 199 
surgery was predictive of developing anxiety in UC [OR 0.98, 95% CI = 0.97 - 1.00] 200 
(22). However, the authors also found that older age was not significantly predictive 201 
of the development of depression in UC, nor was it significantly predictive of either 202 
anxiety or depression in CD (22). In a study of patients <18 years old, Loftus et al 203 
found when age and sex stratified subgroups were studied, patients with current CD 204 
were at increased risk of developing psychological morbidity at follow up (at least 6 205 
months) compared to non-CD controls (25).  206 
 207 
Gender 208 
Two studies concluded that female gender was predictive of the development of 209 
psychological morbidity (22,26) and one found male gender to be more predictive 210 
(25). Ananthakrishnan et al found that female gender was predictive of depression in 211 
both CD [OR = 1.77; 95% CI = 1.16  2.71] and UC [OR = 2.29; 95% CI  1.80  4.76] 212 
following IBD surgery (22). Female gender was also identified as predictive of 213 
depression in a general IBD cohort [HR 1.3, 95% CI: 1.1  1.7] in a study by Panara 214 
et al (26).   215 
 216 
In a study of young patients, Loftus et al stratified according to age and 217 
demonstrated that males with CD have greater risk of psychological morbidity than 218 
their female contemporaries (25). Although adolescent (age range 13 - 17 years) 219 
females were at a twofold increased risk of anxiety disorders [HR 2.45; 95% CI: 1.41 220 
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 4.25] compared to non-CD controls, adolescent males were at even higher risk 221 
[HR 3.01, 95% CI = 1.73  5.24] compared to their peers (25). Within the same 222 
adolescent age group, females were significantly more likely to develop depression 223 
than their peers [HR = 1.74, 95% CI = 1.35  2.25] but were slightly less likely to do 224 
so than males of the same age as compared to controls [HR = 1.99, 95% CI = 1.32  225 
3.02] (25).  226 
 
Comorbidity 227 
Comorbidity, defined as the presence of one or more additional disorders or 228 
diseases occurring alongside the primary disease, is predictive of the development 229 
of psychological morbidity after IBD-related surgery (22). Comorbidity was quantified 230 
using the Charlson Index which gives a score based on the number of coexisting 231 
medical conditions, identified using the International Classification of Diseases IX 232 
definitions for any non-IBD medical condition (29). A score of t3 was predictive of 233 
developing both anxiety and depression across IBD. Patients with CD and a 234 
Charlson Score t3 had greater than a fourfold increased risk of developing 235 
depression after surgery for IBD [OR 4.31, 95% CI = 2.83  6.57] and almost a 236 
twofold increased incidence of developing anxiety [OR 1.84, 95% CI = 1.19  2.84] 237 
(22). Similarly, patients with  UC and comorbidities were at more than a threefold 238 
increased risk of developing both depression [OR 3.37, 95% CI = 2.33  5.97] and 239 
anxiety [OR 3.26, 95% CI = 1.98  5.38] (22). 240 
 241 
Psychological Factors 242 
Gratitude 243 
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Sirois and Wood showed that IBD patients with higher levels of gratitude at baseline 244 
were less likely to develop depressive symptoms after 6 months than those with 245 
lower levels at baseline [r = -0.43, p < 0.01] (27). Gratitude was defined as a life 246 
orientation toward noticing the positive in life, including both thankfulness to others 247 
and a wider sense of appreciation for what one has (27,30).  248 
 249 
Parenting Stress 250 
Guilfoyle et al identified parenting stress as predictive of the development of 251 
depressive symptoms in adolescents with IBD after a 6 month follow-up period [R-252 
change = 0.03, F(1,58) = 35.6, p < 0.05] (24). Baseline parenting stress was 253 
quantified by the frequency and severity of illness-related parenting stress across 254 
four factors (communication, medical care, role functioning and emotional 255 
functioning) (24).  256 
 257 
Symptom Burden 258 
Trindade et al reported that a higher burden of IBD symptomatology predicted the 259 
development of depressed mood [r = 0.25, p < 0.01] (28).  After an 18-month follow 260 
up, the relationship between symptomatology and development of depressed mood 261 
appeared to be regulated by two factors: cognitive fusion (a maladaptive process 262 
that refers to the relationship a person has with his/her own cognitive events); and 263 
brooding (a passive comparison of ones current situation with some unachieved 264 
standard) (28).  265 
  
 
16 
DISCUSSION 266 
This review has identified a range of  physical and psychological factors - including 267 
active or severe disease, medical comorbidity, gratitude and parenting stress - that 268 
may predict the development of psychological morbidity in patients with IBD. Age 269 
and gender specific risks have also been identified, but the relationship is more 270 
complex. 271 
 272 
The ability to identify risk of future development of psychological morbidity in patients 273 
with IBD is important but the evidence in this field is limited. Data is limited by 274 
methodological and design inconsistencies including duration of follow-up and 275 
definitions of psychological morbidity as well as over-representation of patients from 276 
developed countries. The majority of data in the current studies relates to potential 277 
predictive factors derived from cross-sectional studies for which there is a strong 278 
literature base e.g. gender, age, treatment related factors and previous surgery (14279 
18).  Such factors are reported individually rather than as a set of factors that might 280 
have complex relationships and interact to create different levels of risk for the 281 
development of psychological morbidity. Two studies in this review have attempted 282 
to combine factors to create a composite end-point of severe disease, but use 283 
different factors in their analysis (22,26).  Future longitudinal multi-centre studies are 284 
needed to enable modelling of multiple factors in to an algorithm to enable a 285 
psychological morbidity risk score to be obtained.   286 
 287 
The age of patients with IBD may be important in the prediction of psychological 288 
morbidity, with young people identified as at increased risk in this review, supporting 289 
findings in previous research (31). Despite American and European guidelines (32290 
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34), only 12% of adult IBD services (35), compared to 67% of paediatric centres (36) 291 
provide access to a specialist psychologist. Failing to employ a preventative, rather 292 
than reactive, approach to psychological well-being in adult IBD populations (37) is 293 
likely to impact negatively on health risk behaviours and self-management 294 
behaviours, with subsequent costs including from work impairment (38). Young 295 
people transitioning to adult care are also an at-risk group and may require further 296 
psychological assessment and screening of psychological morbidity with the known 297 
increased prevalence of depression through puberty (16). Furthermore, gender-298 
specific risks observed are in line with cross-sectional studies that identify adverse 299 
mental health outcomes in a general population of females (3941).  300 
 301 
This review has highlighted the important relationship between physical and mental 302 
health. More aggressive disease behaviour, comorbidities, and disease activity all 303 
increase the risk of developing psychological morbidity in IBD cohorts (2227). The 304 
definition of aggressive disease behaviour in the paper by Panara included use of 305 
biologics medication. It is likely that the threshold for such treatment may vary across 306 
centres or over time but  together with the other measures used (need for sugery 307 
and perianal disease)  would reasonably be regarded as a marker of a more 308 
aggressive disease course. The relationship between psychological morbidity, 309 
particularly depression, and IBD is complex, but it is imperative that clinicians 310 
recognise the bidirectional relationship between the two (23). Rates of adherence to 311 
medication are lower in patients with depression (12) and mood can also impact on 312 
response to treatment, with the presence of major depressive disorder at baseline 313 
lowering remission rates significantly (42). Targeting these at risk patients, before 314 
they develop psychological morbidity, would help clinicians deliver the most effective 315 
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care as well as avoiding complications encountered from lack of adherence to 316 
medication.  317 
 318 
Psychological factors are also important when predicting the development of 319 
psychological morbidity with higher levels of gratitude protecting against developing 320 
psychological morbidity (27). Those with lower levels of gratitude might benefit from 321 
a psychological intervention, such as a mindfulness based stress reduction or a 322 
positive psychology gratitude intervention (43), when diagnosed with IBD. Parenting 323 
stress has been noted in other situations including in parents of children with 324 
paediatric cancer (44). Interventions including Cognitive Behavioural Therapy or 325 
Mindful Parenting (45) may help parents with methods of coping and reduce their 326 
distress (44,46,47).   327 
 328 
In conclusion, this systematic review demonstrates psychological morbidity in IBD 329 
may be predicted by both physical and psychological factors. However, disease 330 
activity and behaviour may be the only factor with a consistent relationship to the 331 
development of future anxiety and depression. Further longitudinal data from large 332 
IBD cohorts are required to determine whether other well-described associations are 333 
predictive factors. Development of a valid predictive tool for psychological morbidity 334 
in IBD would benefit patients and health care professionals and could improve 335 
efficiency and reduce the cost of health care for patients with IBD.  336 
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